Revenue, last quarter
$1.4B
+7.3% vs same quarter last year
Net income
$32M
+214.3% vs same quarter last year
EPS, diluted
$0.09
+212.5% vs same quarter last year
Operating cash flow
$233M
+70.1% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $5.1B | −$360M |
| FY24 | $4.8B | −$317M |
| FY23 | $4.1B | −$260M |
| FY22 | $3.8B | $6M |
| FY21 | $3.8B | $182M |
| FY20 | $3.4B | −$18M |
| FY19 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | 2.2% | −7.1% |
| FY24 | 3.4% | −6.6% |
| FY23 | 3.1% | −6.3% |
| FY22 | 5.5% | 0.2% |
| FY21 | 8.7% | 4.8% |
| FY20 | 7.6% | −0.5% |
| FY19 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$66M |
| FY24 | −$59M |
| FY23 | −$198M |
| FY22 | $170M |
| FY21 | $680M |
| FY20 | $269M |
| FY19 | - |
- Bausch & Lomb
- Healthcare median
Show the numbers
| Year | Bausch & Lomb | Healthcare median |
|---|---|---|
| FY25 | −7.1% | −30.6% |
| FY24 | −6.6% | −47% |
| FY23 | −6.3% | −58% |
| FY22 | 0.2% | −80.4% |
| FY21 | 4.8% | −71.9% |
| FY20 | −0.5% | −62.2% |
| FY19 | - | −46.3% |